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Abstract
Ovarian cancer G protein-coupled receptor 1 (OGR1) is a proton-sensing molecule that can
detect decreases in extracellular pH that occur during inflammation. Although OGR1 has
been shown to have pro-inflammatory functions in various diseases, its role in autoimmunity
has not been examined. We therefore sought to determine whether OGR1 has a role in the
development of T cell autoimmunity by contrasting the development of experimental autoim-
mune encephalomyelitis between wild type and OGR1-knockout mice. OGR1-knockout
mice showed a drastically attenuated clinical course of disease that was associated with a
profound reduction in the expansion of myelin oligodendrocyte glycoprotein 35-55-reactive
T helper 1 (Th1) and Th17 cells in the periphery and a reduced accumulation of Th1 and
Th17 effectors in the central nervous system. We determined that these impaired T cell
responses in OGR1-knockout mice associated with a reduced frequency and number of
dendritic cells in draining lymph nodes during EAE and a higher production of nitric oxide by
macrophages. Our studies suggest that OGR1 plays a key role in regulating T cell
responses during autoimmunity.
Introduction
Multiple Sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central ner-
vous system (CNS) and is the most common neurological disorder affecting young adults [1].
It is generally thought that the incident attack of MS occurs when an unknown environmental
agent triggers the activation and T helper 1 (Th1) and Th17 differentiation of myelin-reactive
T cells in peripheral lymphoid organs. Upon trafficking to the CNS, pathogenic Th1 and Th17
cells secrete pro-inflammatory cytokines and chemokines that activate resident microglia and
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recruit other immune cells into the CNS. Together, immune cells and the cytotoxic factors
secreted by these cells (i.e., TNF, nitric oxide, reactive oxygen species, glutamate, etc.) damage
oligodendrocytes and axons, which leads to neurological disability [1]. Experimental autoim-
mune encephalomyelitis (EAE) is the common animal model of MS that recapitulates many
immune features of the human disease, and is considered to be useful for modeling factors that
regulate the initiation of autoimmunity [2–4].
One of the metabolic consequences of the development of autoimmune inflammation is
acidification of the extracellular environment [5, 6]. Decreases in extracellular pH occur under
a variety of inflammatory states, largely as a result of increased glycolytic activity and lactate
production by immune cells [7]. For instance, during EAE, extracellular pH decreases from 7.4
to 6.6 in the inflamed spinal cord [5]. In rheumatoid arthritis, more modest decreases in pH (to
7.0–7.4) occur in the synovial fluid [6, 8], which correlate inversely with patient disease activity
score [6]. Recent evidence suggests that ovarian cancer G protein-coupled receptor 1 (OGR1/
GPR68) and other members of the OGR1-family of G protein-coupled receptors (GPCRs) are
sensors of the mild decreases in extracellular pH that occur under inflammatory conditions
[9]. These GPCRs have a set-point of regulation in the physiological range of pH (fully open
between pH = 6.0–6.8 and fully closed at pH = 7.8) [9, 10] and sense changes in proton concen-
tration through histidine residues in their extracellular domains [11]. Upon activation, OGR1
family members mediate pH-induced effects in cells through G protein-coupled increases in
IP3/Ca2+or cAMP [9–12].
Recent emerging evidence suggests that OGR1 is expressed by various immune cells includ-
ing macrophages [13–15], dendritic cells [16], T cells [17], and neutrophils [18] and has a pro-
inflammatory function in various disease states [13, 16]. For example, OGR1-deficient mice
(herein referred to as OGR1-KO mice) exhibit less severe airway inflammation in the ovalbu-
min (OVA)-induced sensitization/challenge model of asthma [16]. It has been also reported
that syngeneic melanoma and prostate cell lines do not grow or engraft as well in OGR1-KO
mice as a result of the higher tumoricidal activity of macrophages [17]. Furthermore, decreases
in pH have been shown to trigger the OGR1-dependent increase in IL-6 secretion by human
airway smooth muscle cells in vitro [19]. Despite these described immune functions, the role of
OGR1 in autoimmunity has not yet been examined.
The objectives of this study were to determine the role of OGR1 in regulating the develop-
ment of autoimmunity and the underlying mechanisms in the EAE model of MS. We observed
that OGR1 deficiency led to a markedly attenuated clinical course of EAE that associated with
a profound decrease in the expansion of myelin oligodendrocyte glycoprotein peptide 35–55
(MOG35-55)-reactive CD4
+ T cells in the periphery and a reduced accumulation of Th1 and
Th17 effector cells in the CNS. Furthermore, we pinpointed that these impaired T cell
responses associated with a higher production of nitric oxide (NO) by macrophages and a
reduced frequency of dendritic cells (DC) and macrophages in inflamed lymph nodes. Our
results indicate that OGR1 has a key role in supporting the expansion of T cells during autoim-
munity, providing the proof of concept that this molecule could be a novel target for therapeu-
tic intervention in T cell-mediated autoimmune diseases such as MS.
Materials and Methods
Ethics Statement
All mice were housed in specific pathogen-free conditions in the Toronto Medical Discovery
Tower animal facility. All experiments were performed under the Animal Use Protocol
(#1125) that was approved by the University Health Network Animal Care Committee. Ani-
mals were euthanized by cervical dislocation that was carried out by trained personnel. Animal
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care was conducted in accordance with the policies and guidelines of the Canadian Council on
Animal Care.
Mice
Female wild type (WT) and 2D2 MOG T cell receptor transgenic mice on the C57BL/6J back-
ground were from the Jackson Laboratory. Breeders of OGR1-KO mice (C57BL/6J back-
ground) were kindly provided by Dr. L. Yan (Indiana University School of Medicine). All mice
were housed in specific pathogen-free conditions at the Toronto Medical Discovery Tower ani-
mal facility (Toronto, Canada). All experiments were performed on female mice aged 8–12
weeks under the Animal Use Protocol (#1125) approved by the University Health Network
Animal Care Committee.
Induction of EAE and Clinical Evaluation
EAE was induced by subcutaneous injection of 100 μg MOG35-55 peptide (Prospec) emulsified
with Complete Freund’s Adjuvant (CFA, 200 μg mycobacterium), followed by intravenous
injection of 100 ng pertussis toxin (List Biological Laboratories, Inc.) on day 0 and day 2 post-
immunization. CFA (4 mg/mL) was prepared by mixing Incomplete Freund’s Adjuvant (Difco
Laboratories) with heat-killedMycobacterium TuberculosisH37Ra (Difco Laboratories). Mice
were observed daily for clinical signs that were scored as follows: 0, no signs; 1, limp tail; 2,
hind limb weakness; 3, complete hind limb paralysis on one or both sides; 4, hind limb paraly-
sis and forelimb weakness; 5, moribund or dead. Mice with a score of 3 or above were adminis-
tered saline subcutaneously (1 mL/day) and were provided Napa nectar in a petri dish on the
bottom of the cage. In addition, their bladder was manually evacuated by gently applying pres-
sure to the bladder. If mice obtained a score of 4, but did not have sufficient mobility to move
towards a food source, they were examined by a clinical veterinarian and were monitored
closely over a 24 h period. If the condition of the mouse did not improve after 24 h, the mouse
was euthanized and was provided a score of 5 for the remainder of the study.
Histological Assessment
Brain and spinal cord sections were collected fromWT and OGR1-KO mice with EAE, fixed in
10% formalin, and embedded in paraffin for histological staining. Sections were stained with
hematoxylin and eosin (H&E) and Luxol Fast Blue. Stained transverse sections of the spinal
cord (N = 10−12/mouse) were scored blindly for the presence of meningitis, perivascular cuffs
and demyelination as described previously [20].
Quantification of CNS Effector CD4+ T cells
Mice were induced for EAE and were sacrificed on day 28 post-immunization. Brain and spinal
cords were collected and CNS mononuclear cells were isolated by Percoll gradient centrifuga-
tion as previously described [21]. Cells were counted and were re-stimulated in vitro in com-
plete RPMI-1640 medium (containing 10% FCS) with 50 ng/mL PMA and 500 ng/mL
ionomycin in the presence of brefeldin A for 4 hours. These cells were then stained with anti-
bodies specific for CD4, IFN-γ and IL-17 and were analyzed by flow cytometry (see details of
antibodies and flow cytometry below).
Measurement of Recall T Cell Response Against MOG35-55
Draining lymph nodes were harvested from mice on day 10 post-immunization and passed
through 40 μM nylon cell strainers (BD Falcon) to obtain single-cell suspensions. Red blood
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cells were lysed by incubation in Lysis Buffer (0.14 M ammonium chloride, 0.02 M Tris,
pH = 7.2) for 2 minutes and cells were counted using an automatic Vi-Cell cell counter (Beck-
man Coulter). Cells were labeled with 0.5 μMCFSE according to product directions (Life Tech-
nologies), were resuspended in complete RPMI-1640 medium and were cultured in 96 well
plates (0.5 x 106/well) together with 1–10 μg/mL MOG35-55 peptide for 3 days. Cells were then
stained with viability dye and anti-CD4 antibody and flow cytometry was performed to deter-
mine the percent of CD4+ T cells that had divided. The levels of IFN-γ and IL-17 were mea-
sured in culture supernatants using ELISA kits (BioLegend).
Measurement of T Cell Proliferation and Differentiation
CD4+ T cells were isolated from spleen and lymph nodes of mice by negative selection using
the MACs separation system (Miltenyi Biotec). Cells were resuspended in complete RPMI and
were plated with soluble anti-mouse CD28 antibody (2 μg/mL) on 96-well plates that were pre-
coated with LEAF purified anti-mouse CD3 antibody (2 μg/mL) (both from BioLegend). For
proliferation assays, cells were first labeled with 0.5 μMCFSE prior to culture. For Th differen-
tiation assays, cells were stimulated without additional reagents (Th0 conditions), in the pres-
ence of 10 μg/mL anti-IL-4 (BioLegend) and 5 ng/mL recombinant mouse IL-12 (Peprotech)
(Th1 conditions), or with 10 μg/mL anti-IL-4, 10 μg/mL anti-IFN-γ (BioLegend), 20 ng/mL
recombinant mouse IL-6 (Peprotech), and 5 ng/mL recombinant human TGF-β (Prospec)
(Th17 conditions). After 5 days, cells were re-stimulated with PMA and ionomycin and stained
with antibodies specific for CD4, IFN-γ and IL-17 as described above.
Preparation of Bone Marrow-Derived Dendritic cells (BMDCs),
Macrophages (BMDMs) and T Cell-Depleted Splenocytes for Co-culture
Studies
Bone marrow cells were flushed from the femurs and tibias of mice using syringes containing
sterile 1 x PBS. Red blood cells were lysed using Lysis buffer (see above) and were resuspended
in complete RPMI. For BMDC generation, bone marrow cells were cultured for 8 days in com-
plete RPMI medium that contained 20 ng/mL GM-CSF (Prospec), which was added to the
culture every 3 days. For BMDM generation, bone marrow cells were cultured for 7 days in
complete RPMI medium that contained 10 ng/mL mouse M-CSF (Prospec), which was added
to the culture every 2–3 days. Bulk APCs were obtained by CD4+ and CD8+ T cell depletion of
splenocytes using the MACs separation system. Bulk APCs, BMDCs, and BMDMs were then
stimulated overnight with 0.1 μg/mL LPS, and were washed and counted prior to co-culture
with T cells.
APC/T Cell Co-culture Assays
For BMDC co-culture studies, 2D2 T cell receptor transgenic CD4+ T cells were isolated from
lymph nodes and spleens of 2D2 mice using the MACs separation system and were labeled
with 0.5 μMCFSE. These cells were then plated together with BMDCs (ratio of 2:1) for 3 days
in the presence of 10 μg/mL MOG35-55.
For bulk APC and BMDM co-culture studies, CD4+ T cells were isolated by negative selec-
tion fromWTmice and plated together at various ratios with T cell-depleted splenocytes or
BMDMs on anti-CD3 antibody-coated (2 μg/mL) 96 well plates. In some experiments, the
medium was supplemented with 10 μM of the nitric oxide synthase 2 (NOS2)-specific inhibi-
tor, L-N6-(1-Iminoethyl) lysine dihydrochloride (L-NIL, R&D Systems). After 3–5 days, cells
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were collected and stained for flow cytometry and supernatants were frozen for cytokine analy-
sis by ELISA assay (BioLegend).
Nitrite Measurements
Supernatants from macrophages stimulated overnight with 0.1 μg/mL LPS were used to mea-
sure levels of nitrite, as a measure of NO production using the Griess Reagent Kit (Life Tech-
nologies) according to methods described in the technical bulletin.
Flow Cytometry
The following mAbs were used for flow cytometry: anti-CD4 (GK1.5), anti-IL-17 (TC11-
18H10.1), anti-IFN-γ (XMG12), anti-CD3 (145-2C11), anti-CD8 (53.6.7), anti-CD11c (N418),
anti-CD11b (M1/70), anti-F4/80 (BM8), anti-CD86 (GL-1), anti-CD80 (16-10A1), anti-CD40
(3/23), anti-PDL1 (10F.9G2), all from BioLegend, anti-NOS2 (CXNFT) from eBioscience and
anti-MHCII (AF6-120.1) from BD Biosciences. Cell viability was assessed using eFluor450
dye (eBioscience). Viable cells were identified as the eFluor450 negative population. Data
were acquired using an LSRII (BD Biosciences) cytometer and analyzed with FlowJo software
(TreeStar).
Statistical Analysis
All data are expressed as mean ± standard error of mean. Data were compared between WT
and OGR1-KO mice using a student’s two-tailed t-test (if data were parametric) or a Mann-
Whitney U test (if data were non-parametric). In addition, the effect of L-NIL on WT and
OGR1-KO cell cultures was investigated using a one-way ANOVA and Tukey post-hoc test. A
value of p<0.05 and below was considered to be significant.
Results
Deficiency in OGR1 Results in Attenuated EAE
OGR1 has recently been shown to regulate the development of tumors [17, 22] and airway
inflammation [16], however its role in autoimmunity is not known. To investigate the role for
OGR1 in T cell-mediated autoimmunity, we induced EAE in OGR1-KO andWT mice via
immunization with MOG35-55/CFA and observed mice for clinical signs over a 28-day period.
As seen in Fig 1A, WT mice started to show signs of disease at day 10 post-immunization and
continued to progress to develop hind limb paralysis, after which they exhibited a partial recov-
ery of hind limb function. In contrast, OGR1-KO mice showed a significantly attenuated dis-
ease course compared to WT mice at nearly all time points examined (Fig 1A and Table 1).
While WT animals had a maximal clinical score of 3.1 (±0.3) with an average cumulative score
of 20.8 (±2.2) after 28 days (Table 1), OGR1-KO mice did not progress beyond a clinical score
of 1.7 (±0.3) and exhibited a cumulative score of 11.6 (±1.7). Histological analysis of hematoxy-
lin/eosin- and Luxol Fast Blue-stained spinal cord sections fromWT and OGR1-KO mice (Fig
1B) revealed that the reduced EAE severity in OGR1-KO mice associated with a ~50% reduc-
tion in the extent of meningeal and perivascular inflammation and demyelination in the spinal
cord white matter compared to levels observed in WTmice (Fig 1C and 1D).
Given that the CNS inflammatory response in EAE is initiated by Th1 and Th17 cells [1],
we next measured the accumulation of Th effector cells in the CNS of OGR1-KO and WTmice
during EAE. To this end, mononuclear cells were isolated from pooled spinal cord and brain
tissue of WT and OGR1-KO mice, and the number and frequencies of IFN-γ- and IL-17-pro-
ducing CD4+ T cells were evaluated by intracellular cytokine staining. As shown in Fig 2B, we
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observed a significantly lower frequency of IFN-γ+ CD4+ T cells in the OGR1-KO CNS com-
pared to WT CNS. OGR1-KO mice also showed significantly reduced numbers of IFN-γ+ and
IL-17+ CD4+ T cells in CNS tissue compared to WT animals (Fig 2C). These data coincide with
the histological analysis of inflammation and suggest that OGR1 regulates the accumulation of
Th1 and Th17 effectors in the CNS during EAE.
OGR1-KOMice Exhibit Impaired Antigen-Specific T Cell Responses
During EAE
The reduced accumulation of Th1 and Th17 effectors in the CNS of OGR1-KO mice during
EAE could have resulted from defects in the priming and expansion of, or cytokine production
by MOG35-55-reactive T cells in the periphery. To address these possibilities, we measured the
recall proliferation and cytokine production by antigen-specific CD4+ T cells in the draining
lymph nodes (dLN) of WT and OGR1-KO mice upon ex vivo culture with MOG35-55. As seen
in Fig 3A and 3B, dLN CD4+ T cells fromWTmice showed a dose-dependent increase in pro-
liferation upon stimulation with increasing concentrations of MOG35-55. In contrast, dLN
CD4+ T cells from OGR1-KO mice showed very little proliferation in response to any
Fig 1. Deficiency in OGR1 results in the attenuation of EAE. (A) EAE was induced in wild type (WT) and OGR1-KOmice by injection of MOG35-55/CFA
and pertussis toxin and mice were observed daily for clinical signs of EAE for 28 days. Data shown are means + SEM of clinical scores obtained from 3
independent experiments that each used N = 5 mice/group. (B-D) In one experiment, cross sections of WT and OGR1-KO spinal cords (N = 10 sections/
mouse) were prepared from N = 8 mice/group and were stained with Luxol Fast Blue and hematoxylin and eosin. Sections were scored blindly for meningeal
and perivascular inflammation and demyelination. (B) shows a representative area of a spinal cord cross section from oneWT and OGR1-KOmouse. The
arrow indicates perivascular infiltration and dashed outlined section indicates area of demyelination. (C) shows the percent of spinal cord quadrants that were
affected by meningeal inflammation or that contained perivascular cuffs. (D) shows the percent of the spinal cord white matter that was demyelinated. In C
and D, values are means + SEM of values obtained in the N = 8 mice/group. *p<0.05, **p<0.01, ***p<0.001 by two-tailed t-test.
doi:10.1371/journal.pone.0148439.g001
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concentration of MOG35-55 tested. OGR1-KO dLN cells also exhibited a lower basal division
than the WT dLN cells, in wells where no exogenous MOG was added. In these wells, the T cell
division observed was likely in response to antigen presenting cells (APC) presenting MOG
peptide that was derived from the emulsion. The higher proliferation of the WT compared to
the OGR1-KO cells at day 10 post-immunization indicates either that the WT dLNs contained
a larger pool of expanded MOG-reactive T cells compared to the OGR1-KO dLNs or that
OGR1-KOMOG reactive T cells had a reduced capacity than WT T cells to proliferate to anti-
gen signals.
Following these trends in T cell proliferation, MOG35-55-elicited IL-17 and IFN-γ produc-
tion was also significantly lowered in dLN cultures established from OGR1-KO versus WT
mice (Fig 3C and 3D). Given that the cytokine production largely followed the T cell prolifera-
tion results, our data strongly suggest that there is failure in the priming or expansion of anti-
gen-specific effector T cells in OGR1-KO animals during EAE.
OGR1-KO CD4+ T Cells Show No Inherent Defects in Their Capacity to
Proliferate and Differentiate
The impaired generation of antigen-specific Th1 and Th17 cells observed in OGR1-KO mice
could have resulted from functional defects in either the T cell compartment or the antigen-
presenting cell (APC) compartment. We therefore first investigated if there were any overt
differences in the T cell compartment between naïve WT and OGR1-KO mice. As seen in
Tables 2 and 3, we did not observe any differences in the total number (Table 2) or percentage
(Table 3) of CD3+, CD4+ or CD8+ T cells in the spleens or lymph nodes of naïve WT and
OGR1-KO mice. We then compared the capacity of WT and OGR1-KO CD4+ T cells to pro-
liferate and produce Th cytokines upon stimulation with anti-CD3 and anti-CD28 antibod-
ies. As shown in Fig 4A, WT and OGR1-KO T cells exhibited a similar extent of proliferation
Table 1. Clinical features of disease in OGR1-KO andWTmice.
Clinical feature WT OGR1-KO
Maximal score:
Experiment 1 3.2 (0.3) 1.8 (0.3) ***
Experiment 2 3.1 (0.2) 1.6 (0.2) ***
Experiment 3 3.0 (0.4) 1.7 (0.4) ***
Average: 3.1 (0.3) 1.7 (0.3) ***
Day of Onset:
Experiment 1 10.0 (0) 10.0 (0)
Experiment 2 10.0 (0) 10.4 (0.9)
Experiment 3 10.0 (0) 10.0 (0)
Average: 10.0 10.1
Cumulative Score:
Experiment 1 21.8 (1.2) 12.4 (1.3) ***
Experiment 2 20.8 (2.7) 10.7 (2.0) ***
Experiment 3 19.9 (2.3) 11.6 (1.7) ***
Average: 20.8 (2.2) 11.6 (1.7) ***
Each experiment used N = 5/group. Values are means (SEM). The incidence of EAE was 100% in all three
experiments that were performed.
*** p<0.0001 by Student’s t-test (two-tailed).
doi:10.1371/journal.pone.0148439.t001
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as measured by CFSE dilution upon stimulation with varying concentrations of anti-CD3
and anti-CD28. In addition, WT and OGR1-KO CD4+ T cells secreted similar levels of IL-17
and IFN-γ upon anti-CD3 and anti-CD28 stimulation (Fig 4B). Next, to assess the ability of
WT and OGR1-KO CD4+ T cells to differentiate into Th1 and Th17 cells, purified CD4+ T
cells were stimulated with anti-CD3 and anti-CD28 antibodies under Th1 or Th17 polarizing
conditions; however we detected no differences in the percentage of IFN-γ+ or IL-17+ CD4+
cells between OGR1-KO and WT cultures (Fig 4C–4E). Overall, these data indicate that
OGR1 deficiency does not alter the ability of CD4+ T cells to proliferate or differentiate in
vitro.
Fig 2. The frequency and total number of Th1 and Th17 cells were significantly reduced in OGR1-KO CNS during EAE.WT and OGR1-KOmice were
immunized with MOG35-55/CFA and were provided pertussis toxin and at 28 days post-immunization brains and spinal cords were removed and CNS
mononuclear cells were isolated by Percoll gradient centrifugation. Lymphocytes were counted, restimulated in vitro with PMA and ionomycin in the presence
of brefeldin A, and stained with antibodies specific for CD4, IFN-γ and IL-17. (A-B) The percentages of IFN-γ+ and IL-17+ cells within the CD4+ gate were
measured by flow cytometry and (C) the total cell number of each population was calculated. Data are means + SEM of individual mice (N = 3/group) and are
representative of 3 independent experiments. **p<0.01, ***p<0.001 by two-tailed t-test. Similar studies were conducted at day 10 post-immunization with
similar results.
doi:10.1371/journal.pone.0148439.g002
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APC From OGR1-KOMice Have a Reduced Capacity to Support T Cell
Proliferation
Since there appeared to be no inherent defects in the T cell compartment in OGR1-KO mice,
we investigated whether the APC compartment was altered in these mice. First, we examined
macrophage and dendritic cell populations in the spleen and LNs of naive WT and OGR1-KO
mice; however we detected no aberrations in either the total cell number or frequencies of these
Fig 3. OGR1 deficiency impairs the generation of antigen-specific T cells. (A-B) Mice (N = 6/group) were immunized with MOG35-55/CFA and at 10 days
post-immunization draining lymph nodes (dLN) were removed and were pooled together. Lymph node mononuclear cells were labeled with CFSE and
cultured with MOG35-55 peptide (0–10 μg/mL) for 3 days. Cells were collected and stained with anti-CD4 antibody and the percentage of divided CD4
+ cells
was analyzed by CFSE dilution. (C-D) Supernatants from the cultures were used to measure the levels of IL-17 (C) or IFN-γ (D) by ELISA. Data are means
+ SEM of values obtained from triplicate cultures and are representative of 3 independent experiments. *p<0.05, **p<0.01, ***p<0.001 by t-test (two-tailed).
doi:10.1371/journal.pone.0148439.g003
Table 2. Total cell numbers x 106 in NaïveWT and OGR1-KOmice.
Cell Type WT Spl OGR1-KO Spl WT LN OGR1-KO LN
CD3+ 18.72 (2.39) 17.36 (1.18) 6.90 (0.63) 8.59 (0.44)
CD4+ 10.53 (0.60) 10.01 (0.14) 3.97 (0.19) 4.56 (0.19)
CD8+ 7.33 (0.64) 6.57 (0.38) 2.82 (0.17) 3.11 (0.14)
CD11c+ 0.48 (0.16) 0.49 (0.18) 0.04 (0.02) 0.03 (0.01)
F480/CD11b+ 0.19 (0.01) 0.17 (0.04) 0.005 (0.004) 0.003 (0.001)
n = 4 mice per group. Values are means (SEM).
No signiﬁcant differences were observed between WT and OGR1-KO data by two-tailed t-test.
doi:10.1371/journal.pone.0148439.t002
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APC populations in these immune organs in OGR1-KO mice (Tables 2 and 3). Next, to deter-
mine if there were any differences in these APC populations during EAE, we also quantified
CD11c+ and F4/80+ cells in the dLNs at 10 days post-immunization. Under these conditions,
we detected a 40% reduction in the frequency (Fig 5A) and a 75% reduction in the total number
(Fig 5B) of CD11c+ and F4/80+ cells in OGR1-KO compared to WT animals. This finding sug-
gested a possible defect in the maturation or recruitment of APC to dLNs during EAE.
We next investigated the ability of WT and OGR1-KO APCs to prime CD4+ T cells by co-
culturing an equal number of T cell-depleted splenocytes (as a source of bulk APC) fromWT
or OGR1-KO mice with WT T cell responders in the presence of anti-CD3. We observed that
CD4+ T cells co-cultured with OGR1-KO APCs proliferated to a much lesser extent compared
to CD4+ T cells co-cultured with WT APCs (Fig 6A and 6B). In addition, we detected a lower
frequency of Th1 effector cells in the co-cultures that contained OGR1-KO APC versus those
that contained WT APC (Fig 6C and 6D). We also measured frequencies of IL-17+ cells in
these co-cultures, but observed very low percentages of these cells in both groups (data not
shown). These data indicate that deficiency in OGR1 is associated with a lowered frequency of
DCs and macrophages in dLNs during EAE and a reduced capacity of APC to support Th cell
expansion.
OGR1-KOmacrophages have a greater ability thanWTmacrophages to
inhibit the proliferation and cytokine production by CD4+ T cells
Next we explored which type of APC was responsible for the attenuated disease observed in
KO animals. In the MOG peptide-based model of EAE, dendritic cells have been implicated as
having the major role in the priming of myelin-reactive T cells [23]. We therefore compared
the ability of OGR1-KO and WT bone marrow-derived dendritic cells (BMDC) to prime CD4+
T cells. As shown in S1A Fig, we observed no defects in the maturation of BMDCs in response
to GM-CSF, nor in the ability of these cells to express MHC Class II or co-stimulatory mole-
cules after overnight stimulation with LPS (S1B Fig). Similarly, when BMDCs from OGR1-KO
mice were co-cultured with 2D2 T cell receptor transgenic T cells in the presence of MOG35-55
antigen, we observed that OGR1-KO BMDCs were just as effective as WT BMDCs at support-
ing CD4+ T cell proliferation (S1C and S1D Fig). Together these findings suggest that dendritic
cell differentiation and function were not compromised in OGR1-KO mice.
Since macrophages also function as APC and play important roles in EAE development
[24–26], we next examined if macrophage function was altered by OGR1 deficiency. Similar to
findings for BMDCs, we did not observe any differences in the yields or maturation status of
WT and OGR1-KO bone marrow-derived macrophages (BMDM) (S2A and S2B Fig). Yet con-
sistent to our findings of bulk splenocytes, we observed that CD4+ T cells exhibited impaired
Table 3. Percent of Live Cells in NaïveWT and OGR1-KOmice.
Cell Type WT Spl OGR1-KO Spl WT LN OGR1-KO LN
CD3+ 30.40 (3.88) 31.67 (2.17) 66.87 (6.11) 69.87 (3.65)
CD4+ 17.11 (0.98) 18.26 (0.26) 38.51 (1.88) 39.26 (0.66)
CD8+ 11.92 (1.04) 11.98 (0.69) 27.39 (1.67) 29.69 (2.20)
CD11c+ 0.78 (0.25) 0.90 (0.32) 0.39 (0.21) 0.24 (0.09)
F480/CD11b+ 0.31 (0.01) 0.31 (0.07) 0.05 (0.03) 0.02 (0.01)
n = 4 mice per group. Values are means (SEM).
No signiﬁcant differences were observed between WT and OGR1-KO data by two-tailed t-test.
doi:10.1371/journal.pone.0148439.t003
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proliferation (Fig 7A and 7B) and Th cytokine production (Fig 7C and 7D) when co-cultured
with OGR1-KO compared to WT macrophages. We also noted that there was a tendency for a
higher frequency of dead (positive for viability dye) CD4+ T cells in the co-cultures that con-
tained OGR1-KO versus WT BMDMs (18.7 + 0.4 in OGR1-KO versus 8.7 + 3.7 in WT, Mann-
Fig 4. OGR1-KO T cells show no inherent defects in their capacity to proliferate and differentiate. (A) CD4+ T cells were isolated fromWT and
OGR1-KO spleen and lymph nodes (N = 4 mice/group), were pooled and labeled with CFSE and stimulated with anti-CD3 and anti-CD28 (2 μg/ml)
antibodies. After 3 days of culture, cells were collected and stained with anti-CD4 antibody and cell proliferation was measured by CFSE dilution. Data are
means + SEM of triplicate cultures and are representative of 4 independent experiments. (B) WT or OGR1-KO CD4+ T cells were cultured with soluble anti-
CD28 antibody (2 μg/ml) on anti-CD3-coated (2 μg/ml) plates for 5 days and then were re-stimulated with PMA and ionomycin and IL-17 and IFN-γ were
measured by ELISA. Data are means + SEM of triplicate cultures and are representative of 3 independent experiments. (C-E) CD4+ T cells fromWT or
OGR1-KOmice were stimulated with anti-CD3 and anti-CD28 (both at 2 μg/ml) under Th1 or Th17 polarizing conditions. After a 5-day incubation, cells were
re-stimulated with PMA and ionomycin in the presence of brefeldin A for an additional 4 hours. Cells were then collected and stained with antibodies for CD4,
IFN-γ or IL-17 and the percentage of IFN-γ+ and IL-17+ CD4+ cells was calculated. Results in C show representative FACs plots while data in D and E are
means + SEM of triplicate cultures. Data shown are from one of three experiments that were performed. ns = not significant, by Student’s t-test (two-tailed).
doi:10.1371/journal.pone.0148439.g004
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Whitney U test, P = 0.055). Collectively, these data suggest that OGR1-KO macrophages are
more potent than WTmacrophages at suppressing the proliferation of Th1 and Th17 effector
cells.
Altered NO Production Accounts for the Differential Ability of OGR1-KO
andWTMacrophages to Support T Cell Proliferation
To further explore what feature was responsible for the differential effect of OGR1-KO and
WTmacrophages on T cell proliferation, we compared the expression of co-stimulatory and
co-inhibitory molecules and the production of cytokines between OGR1-KO andWT
BMDMs. As shown in S2B Fig, WT and OGR1-KO macrophages expressed similar levels of
CD86, CD80, CD40, MHCII and PD-L1 after overnight stimulation with LPS. Similarly, we
Fig 5. The frequency and total number of macrophages and DCs are reduced in OGR1-KO dLN after immunization. (A-B) Draining lymph nodes
(dLN) were removed fromWT and OGR1-KOmice at 10 days post-immunization with MOG35-55/CFA. The frequencies (A) and total number (B) of CD11c
+
and F4/80+ cells were determined by flow cytometry. Data in A are representative flow plots, while data in B are means + SEM of values obtained from N = 6
mice/group. Data shown are representative of 2 independent experiments.
doi:10.1371/journal.pone.0148439.g005
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detected no significant differences in the production of pro-inflammatory (IL-12p40, IL-
12p70, IL-6) or anti-inflammatory (IL-10 and TGFβ) cytokines between OGR1-KO or WT
macrophages after LPS stimulation (S2C Fig). We also investigated the productions of IL-1β
and IL-23 in culture supernatants from LPS-elicited macrophages, but did not detect these
cytokines above background levels (data not shown).
Past studies have shown that macrophages can suppress T cell proliferation through nitric
oxide (NO) secretion [27–31]. In addition, NO-induced immunosuppression and T cell killing
have been identified as a mechanism of how macrophages attenuate EAE induction [32, 33].
We therefore examined whether there were differences in the secretion of NO production by
WT and OGR1-KO macrophages. Interestingly, after stimulation with LPS, OGR1-KO macro-
phages secreted NO at ~ 4-fold higher levels than WT macrophages, as detected by nitrite
assay (Fig 8A). The increased NO secretion by OGR1-KO relative to WT macrophages corre-
lated with an increased expression of iNOS at the protein level (Fig 8B). To determine if this
Fig 6. APC fromOGR1-KOmice have a decreased ability to support T cell proliferation and cytokine production. Splenocytes were isolated fromWT
and OGR1-KOmice and T cells were depleted by MACs separation as described in the Methods. T cell-depleted splenocytes (APC) were stimulated with
LPS overnight, washed and co-cultured (1:1 ratio) with CFSE-labeled WT CD4+ T cells that were plated onto anti-CD3 antibody-coated plates. The
percentage of divided CD4+ cells (A-B) was examined after 3 days of culture. Data shown are from 4 individual experiments. (C-D) Cells were stimulated with
PMA, ionomycin in the presence of brefeldin A for an additional 4 hours and intracellular staining for IFN-γ was performed. (C) shows representative FACs
plots of IFN-γ expression versus side scatter of CD4+ cells and (D) shows the means + SEM of values obtained from 3 individual experiments. *p<0.05,
**p<0.01 by t-test (two-tailed).
doi:10.1371/journal.pone.0148439.g006
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increased NO production was the factor that accounted for the reduced T cell proliferation in
the macrophage/T cell co-cultures, we performed co-culture experiments in the presence and
absence of the NOS2-specific inhibitor, L-NIL. Consistent with our previous observations, cul-
ture with OGR1-KO macrophages resulted in reduced levels of T cell proliferation and IFN-γ
and IL-17 secretion compared to culture with WT macrophages (Fig 8C–8E). Importantly,
treatment with 10 μM L-NIL significantly increased the proliferation and the cytokine produc-
tion by CD4+ T cells, particularly in the co-cultures that contained the OGR1-KO macrophages
(Fig 8C–8E). Together, these data confirm an immunosuppressive role for macrophage-
derived NO on T cell proliferation and further suggest that the higher macrophage NO secre-
tion contributed to the impaired T cell responses in OGR1 mice.
Discussion
Although considerable insight has been gained into the pathobiological and immunological
mechanisms involved in MS and the animal model EAE, the etiology of MS has proven elusive
and new targets for therapy are continually being evaluated. Recent studies have implicated a
Fig 7. OGR1-KOmacrophages have a greater ability thanWTmacrophages to inhibit the proliferation and cytokine production by CD4+ T cells.
CFSE-labeled WT CD4+ T cells were plated onto anti-CD3 antibody-coated plates and co-cultured with either WT or OGR1-KOmacrophages (mac) that had
been pre-stimulated with 0.1 μg/mL LPS. The percentage of divided CD4+ cells (A-B) was examined after a 3-day incubation period. (A) shows
representative data while (B) shows means + SEM of values obtained from 6 individual experiments. *p< 0.05 by Student’s t-test (two-tailed). (C-D) WT
CD4+ T cells were co-cultured with either WT or OGR1-KOmacrophages, at a ratio of 1:0.2, for 5 days (C) or 4 days (D) and supernatants were used to
measure the levels of IFN-γor IL-17 by ELISA. Data are means + SEM of triplicate cultures and are representative of 3 independent experiments. *p<0.05,
**p<0.01 Student’s t-test (two-tailed).
doi:10.1371/journal.pone.0148439.g007
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pro-inflammatory role for the proton-sensing GPCR, OGR1, in a variety of diseases including
allergy and cancer; however whether this molecule has a similar role in autoimmunity had not
been examined. Here we explored the role of OGR1 in the development of EAE and observed
that OGR1-KO mice exhibited a striking attenuation of CNS inflammation during EAE that
associated with a reduced expansion of MOG35-55-reactive Th1 and Th17 cells in the periphery
and a reduced accumulation of Th1 and Th17 effector cells in the CNS. In addition, our studies
elucidated that impaired T cell responses in OGR1-KO mice associated with a reduction in the
numbers of DCs and macrophages in dLNs during EAE and higher production of NO by mac-
rophages. Taken together, our studies suggest that OGR1 plays an important role in controlling
T cell expansion in the early stages of EAE.
Our finding that OGR1-KO mice exhibited a defective expansion of Th cells during EAE is
consistent with previous observations of reduced adaptive immune responses in OGR1-KO
mice in a syngeneic prostate tumor model [17] and in the OVA-induced sensitization/chal-
lenge model of asthma [16]. In the prostate cancer model, it was observed the spleen mononu-
clear cells that were harvested from OGR1-KO-tumor-bearing mice exhibited impaired
productions of both pro- and anti-inflammatory cytokines compared to WT counterparts
Fig 8. Differential NO Production Accounts for the Differential Ability of OGR1-KO andWTMacrophages to Support T Cell Proliferation. (A) WT and
OGR1-KOmacrophages were stimulated with 0.1 μg/mL LPS overnight and supernatants were collected and analyzed for nitrite concentration using the
Griess assay. Data are means + SEM of values obtained from N = 5 mice/group. (B) The expression of iNOS was examined by flow cytometry in WT (solid
line) and OGR1-KO (dashed line) macrophages after stimulation with 0.1 μg/mL LPS overnight. Histograms of cells positive for iNOS, within the CD11b+F4/
80+ gate, are shown. Staining with the isotype control antibody (dotted line) is also shown. This panel is representative of 3 experiments that were performed
on N = 3 mice/group. (C-E) WT CD4+ T cells and either WT or OGR1-KOmacrophages (mac) were co-cultured in the presence or absence of 10 μM L-NIL.
(C) The percent of divided CD4+ cells was determined by staining CFSE-labeled T cells in the co-culture with anti-CD4 antibody after a 3-day incubation.
(D-E) Supernatants were collected and analyzed for IFN-γ and IL-17 by ELISA. Values in C-E are means + SEM of results from triplicate cultures and are
representative of 3 independent experiments that were performed. *p<0.05, **p<0.01, ***p<0.001 by Student’s t-test (two-tailed) or one-way ANOVA.
doi:10.1371/journal.pone.0148439.g008
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upon re-challenge with tumor cells ex vivo [17]. Similarly, in the asthma model, it was observed
that OGR1-KO mice exhibited reduced airway inflammation thanWT mice that associated
with lowered Th2 cytokine production and decreases in plasma OVA-specific IgE [16]. Further
consistent with a pro-inflammatory role for OGR1, a recent study reported that OGR1-KO
mice also develop less severe colitic inflammation against enteric antigens in the IL-10-/- model
of irritable bowel disease [13]. Collectively, these results suggest that OGR1-KO mice are less
able to mount T cell adaptive immune responses, regardless of the nature of the inciting anti-
gen (i.e., ovalbumin, MOG, tumor cells, microbiota) or the Th bias of the disease model.
Regarding the cellular mechanism of the reduced T cell expansion in OGR1-KO mice, our
data ruled out a role for OGR1 in the T cell compartment, since OGR1-KO mice did not
exhibit any defects in the frequencies of T cells in peripheral lymphoid organs, nor in the ability
of these cells to proliferate and differentiate upon anti-CD3 and anti-CD28 stimulation.
Instead, our studies identified a number of defects in the APC compartment that associated
with the impaired Th1 and Th17 responses in OGR1-KO mice: (1) OGR1-KO mice exhibited a
reduced frequency and number of dendritic cells in inflamed lymph nodes during EAE and (2)
OGR1-KO macrophages exhibited a higher production of NO in response to innate stimuli.
Regarding APC numbers, we had observed that OGR1-KO mice exhibited a lowered fre-
quency of macrophages and DCs in the dLNs compared to WT mice at 10 days post-immuni-
zation. Differences in the frequencies of these cells were not apparent in the lymph nodes of
naive WT versus OGR1-KO mice. We also did not observe a difference in the ability of
OGR1-KO DCs or macrophages to differentiate from bone marrow precursors in culture.
Thus, we speculate that the reduced frequency of these DCs and macrophages in the
OGR1-KO dLNs during EAE is either (1) a secondary consequence of the OGR1-KO lymph
nodes being less inflamed (less chemokines produced to attract DCs and macrophages), or (2)
is due to a migratory defect in APC populations in the OGR1-KO mouse. In regard to the lat-
ter, past studies have provided evidence for a migratory defect of macrophages and DCs in the
OGR1-KO mouse. Li and colleagues reported that OGR1-KO mice exhibited a defect in the
recruitment of macrophage precursors to the peritoneum after thioglycollate injection [14].
Furthermore, Aoki et al. reported in an asthma model that OVA-pulsed DCs from OGR1-KO
mice were less able than WT DCs to migrate to the peribronchial lymph nodes to cause airway
inflammation [16]. This group further showed that this defective migration of the OGR1-KO
DCs correlated with lowered expression of CCR7 by OGR1-KO DCs [16]. Whether, this mech-
anism also accounts for the lowered numbers of DCs or macrophages observed in OGR1-KO
dLNs during EAE is unclear and will be examined in future studies.
In addition to the reduction in the frequency of DCs, we further observed that OGR1-KO
macrophages produced higher levels of NO than WTmacrophages upon LPS stimulation. This
observation is consistent with previous findings in the prostate cancer model, where it was
reported that lowered tumor engraftment in OGR1-KO mice correlated with higher tumor
expression of NOS2 and higher macrophage tumoricidal activity [17]. Given that high NOS2
expression is a defining feature of pro-inflammatory or M1 macrophages [34], Yan and col-
leagues had also concluded that OGR1 deficiency resulted in a shift from an M2 towards an
M1 macrophage phenotype [17]. However, we profiled the expression levels of a number of
markers and cytokines known to be enriched in M1 macrophages (IL-12p40, IL-12p70, IL-6,
MHC Class II, CD80, CD86) [34], yet observed no differences between WT and OGR1-KO
macrophages. Thus, we conclude that OGR1 activity does not necessarily shift macrophage
profile fromM1 to M2, but negatively regulates one aspect of macrophage function, arginine
metabolism and the production of NO. Thus, OGR1 joins a growing list of factors (i.e., IFN-γ,
TNF, IL-1β, IL-33, osmolarity, hypoxia) that regulate NO production by macrophages [35].
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Our finding that treatment with L-NIL abrogated the suppressive effect of OGR1-KO mac-
rophages on T cell proliferation also pointed to the higher NO production as a cause of the T
cell immunosuppression. Notably, we observed that T cell proliferation was also enhanced by
L-NIL treatment in the co-cultures that contained the WT macrophages; albeit to a more lim-
ited extent than OGR1-KO cells. This latter observation is consistent with previous findings of
inhibition of T cell expansion by macrophage-derived NO inWT mice [24–27] and reports
that blockade of NOS2 activity or genetic deficiency in NOS2 worsens Th effector function
during EAE [32, 33, 36], whereas treatment with NO donors is protective in this disease [37].
Future studies will determine whether there is a link between the dysregulated NO production
by OGR1-KO macrophages and the defective T cell expansion in OGR1-KO mice during EAE.
Though our study did not elucidate the mechanism of how NO inhibited T cell prolifera-
tion, past studies have observed that macrophage-derived NO can lead to reductions in the
tyrosine phosphorylation of Jak3/STAT5 downstream of the IL-2R [38, 39]. It was further
shown that this effect of NO on Jak3 was reversed by guanylate cyclase inhibitors implicating
the classic pathway of guanylate cyclase activation and cGMP generation in NO-mediated
immunosuppression [38]. In addition, studies in other cell types have demonstrated that NO
can interfere with tyrosine phosphorylation in cells through cGMP-independent mechanisms
including formation of peroxynitrate and tyrosine nitration [35]. Thus, the enhanced NO pro-
duction by OGR1-KO macrophages may have inhibited T cell proliferation through a variety
of mechanisms.
A previous study reported that pH decreases to 6.6 in the interstitial fluid in the inflamed
spinal cord during EAE [5]. Though we did not measure pH within the inflamed lymph nodes,
we noted modest decreases in pH in our in vitro cultures of dLNs in buffered culture media
(from 7.7 in the wells without added peptide to 7.2–7.3 in wells containing peptide). These
decreases were in a range known to activate OGR1 [9]. These findings warrant future studies to
determine how decreases in pH activate OGR1 to modulate NOS2 expression in macrophages.
In addition, past reports have demonstrated that activation of OGR1 through extracellular
acidification leads to increases in intracellular calcium through phospholipase C/IP3 signaling
in various cell types studied and triggers an accumulation of cAMP in human vascular smooth
muscle cells [40]. Thus, studies investigating the signaling pathways that operate downstream
of OGR1 in macrophages will also help to further understand the molecular mechanisms by
which NOS2 expression is regulated.
In addition to inhibiting T cell proliferation, NO is reported to promote Th1 polarization of
CD4+ T cells [41–43]. In this regard, it has been shown that treatment with chemical NO
donors promotes Th1 differentiation by upregulating IL-12 receptor β2 expression [43] and
inhibits Th17 differentiation through tyrosine nitration on RORγt [41] or through upregula-
tion of the aryl hydrocarbon receptor in T cells [42]. Moreover, a number of studies have
reported that macrophage-derived NO can induce T cell apoptosis [31, 44]. While we did note
a tendency for higher T cell death in the co-cultures that contained the OGR1-KO macro-
phages, we did not observe any indications in our in vivo or in vitro studies that OGR1-defi-
ciency or L-NIL treatment altered the ratio of Th1 to Th17 cells. The discrepancy between our
data and past findings likely relates to relatively modest changes in NO production (4-fold
increase) that occurred with OGR1-deficiency. In support of this notion, it is reported that con-
centrations of chemical NO donors required to inhibit T cell proliferation (10–100 μM), are
lower than the levels that induce T cell apoptosis or inhibit Th17 differentiation (>100 μM)
[42, 44]. Overall, our findings suggest that OGR1 modulates NO production by macrophages
within a modest range to selectively impact T cell proliferation.
In addition to mediating immunosuppression and T cell death, NO has a number of func-
tions that may be detrimental to EAE and MS [45–47]. For example, treatment with NO
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donors is reported to increase the permeability of the blood brain barrier in rats [48], which
may increase the migration of immune cells in the CNS. Furthermore, in vitro studies have
demonstrated that NO is a major cytotoxic factor for oligodendrocytes [49, 50] and neurons
[51]. Reactive nitrogen species and reactive oxygen species also damage mitochondria within
neurons, which is thought to be the major pathological factor underlying MS progression [52].
Our finding that OGR1-KO mice were still susceptible to EAE despite the profound suppres-
sion of T cell expansion was somewhat surprising and hints that OGR1 may modulate more
distal events in EAE development such as immune cell recruitment to the CNS or inflamma-
tion within the EAE lesion. Future experiments using an adoptive T cell transfer approach will
help to further distinguish the role of OGR1 on T cell priming from more distal mechanisms in
EAE development.
In conclusion, our data demonstrate that OGR1 deficiency results in attenuated autoim-
mune inflammation due to a defect in the expansion of myelin-reactive T cells in the periphery.
These results suggest that manipulating OGR1 activity may be a novel way of modulating T
cell responses in autoimmunity and other T cell-mediated diseases.
Supporting Information
S1 Fig. BMDCs from OGR1-KO mice show no developmental or functional defects. (A)
BMDCs were grown from the bone marrow of WT and OGR1-KO mice in the presence of
GM-CSF. After 8 days, cells were stimulated overnight with LPS. Shown is a representative
plot of CD11c+ antibody staining of these cells. The number of cells collected from plates
was also similar in the 5 experiments that were performed. (B) Flow analysis was also per-
formed to measure the cell surface expression of CD86, CD80, CD40, MHC Class II, and
PD-L1 on WT (solid line) and OGR1-KO (dashed line) CD11c+ DCs. Shown are representa-
tive FACs plots from one experiment of 4 that were performed. (C-D) CD4+ T cells were
isolated from spleen and LNs from 2D2 mice, labeled with CFSE and co-cultured with
either WT or OGR1-KO BMDCs at 2:1 ratio in the presence or absence of MOG35-55 peptide.
After 3 days, cells were collected, stained with anti-CD4 antibody and the percentage of
divided cells was analyzed by flow cytometry by measuring CFSE dilution on the CD4+ popu-
lation.
(TIF)
S2 Fig. BMDMs from OGR1-KOmice show no developmental or cytokine defects. (A)
BMDMs were grown from the bone marrow of WT and OGR1-KO mice in the presence of
M-CSF and were stimulated overnight with 0.1 μg/mL LPS and then stained with antibodies to
CD11b, F4/80, CD86, CD80, CD40, MHC Class II and PDL1. (A) Shows representative FACs
plots of CD11b+ and F480+ staining in BMDM cultures. (B) Representative histograms of
the expression of co-stimulatory markers onWT (solid line) and OGR1-KO (dashed line)
CD11b+F4/80+ macrophages. Isotype controls are shown as dotted lines. (C) Cytokines were
measured in either WT or OGR1-KO macrophage supernatants at 24 h post-LPS stimulation
by ELISA assay. Data are means + SEM of values obtained from 8 cultures. ns = not significant
by t-test (two-tailed).
(TIF)
Acknowledgments
The authors would like to thank Dr. Libo Yan for providing breeders for OGR1-KO mice and
Dr. Julia Gao for technical help with the EAE experiments.
OGR1 Deficiency Is Protective in EAE
PLOSONE | DOI:10.1371/journal.pone.0148439 February 1, 2016 18 / 21
Author Contributions
Conceived and designed the experiments: CAD FLZ XL SED LZ YX. Performed the experi-
ments: CAD FLZ XL. Analyzed the data: CAD FLZ XL SED LZ. Contributed reagents/materi-
als/analysis tools: YX LZ SED. Wrote the paper: CAD SED LZ.
References
1. Prat E, Martin R. The immunopathogenesis of multiple sclerosis. Journal of rehabilitation research and
development. 2002; 39(2):187–99. PMID: 12051463
2. Rangachari M, Kuchroo VK. Using EAE to better understand principles of immune function and autoim-
mune pathology. Journal of autoimmunity. 2013; 45:31–9. doi: 10.1016/j.jaut.2013.06.008 PMID:
23849779
3. Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE)
model of MS: utility for understanding disease pathophysiology and treatment. Handbook of clinical
neurology. 2014; 122:173–89. doi: 10.1016/B978-0-444-52001-2.00008-X PMID: 24507518
4. Rao P, Segal BM. Experimental autoimmune encephalomyelitis. Methods in molecular biology. 2012;
900:363–80. doi: 10.1007/978-1-60761-720-4_18 PMID: 22933079
5. Friese MA, Craner MJ, Etzensperger R, Vergo S, Wemmie JA, Welsh MJ, et al. Acid-sensing ion chan-
nel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Nature medicine. 2007; 13(12):1483–9. PMID: 17994101
6. Fujii W, Kawahito Y, Nagahara H, Kukida Y, Seno T, Yamamoto A, et al. Monocarboxylate transporter
4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthri-
tis. Arthritis & rheumatology. 2015.
7. Lardner A. The effects of extracellular pH on immune function. Journal of leukocyte biology. 2001; 69
(4):522–30. PMID: 11310837
8. Farr M, Garvey K, Bold AM, Kendall MJ, Bacon PA. Significance of the hydrogen ion concentration in
synovial fluid in rheumatoid arthritis. Clinical and experimental rheumatology. 1985; 3(2):99–104.
PMID: 4017318
9. Seuwen K, Ludwig MG, Wolf RM. Receptors for protons or lipid messengers or both? Journal of recep-
tor and signal transduction research. 2006; 26(5–6):599–610. PMID: 17118800
10. Wei WC, Jacobs B, Becker EB, Glitsch MD. Reciprocal regulation of two G protein-coupled receptors
sensing extracellular concentrations of Ca2+ and H. Proceedings of the National Academy of Sciences
of the United States of America. 2015; 112(34):10738–43. doi: 10.1073/pnas.1506085112 PMID:
26261299
11. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, et al. Proton-sensing G-protein-cou-
pled receptors. Nature. 2003; 425(6953):93–8. PMID: 12955148
12. Tomura H, Wang JQ, Komachi M, Damirin A, Mogi C, Tobo M, et al. Prostaglandin I(2) production and
cAMP accumulation in response to acidic extracellular pH through OGR1 in human aortic smooth mus-
cle cells. The Journal of biological chemistry. 2005; 280(41):34458–64. PMID: 16087674
13. de Valliere C, Wang Y, Eloranta JJ, Vidal S, Clay I, Spalinger MR, et al. G Protein-coupled pH-sensing
Receptor OGR1 Is a Regulator of Intestinal Inflammation. Inflammatory bowel diseases. 2015; 21
(6):1269–81. doi: 10.1097/MIB.0000000000000375 PMID: 25856770
14. Li H, Wang D, Singh LS, Berk M, Tan H, Zhao Z, et al. Abnormalities in osteoclastogenesis and
decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1. PloS one.
2009; 4(5):e5705. doi: 10.1371/journal.pone.0005705 PMID: 19479052
15. Mogi C, Tobo M, Tomura H, Murata N, He XD, Sato K, et al. Involvement of proton-sensing TDAG8 in
extracellular acidification-induced inhibition of proinflammatory cytokine production in peritoneal macro-
phages. Journal of immunology. 2009; 182(5):3243–51.
16. Aoki H, Mogi C, Hisada T, Nakakura T, Kamide Y, Ichimonji I, et al. Proton-sensing ovarian cancer G
protein-coupled receptor 1 on dendritic cells is required for airway responses in a murine asthma
model. PloS one. 2013; 8(11):e79985. doi: 10.1371/journal.pone.0079985 PMID: 24244587
17. Yan L, Singh LS, Zhang L, Xu Y. Role of OGR1 in myeloid-derived cells in prostate cancer. Oncogene.
2014; 33(2):157–64. doi: 10.1038/onc.2012.566 PMID: 23222714
18. Murata N, Mogi C, Tobo M, Nakakura T, Sato K, Tomura H, et al. Inhibition of superoxide anion produc-
tion by extracellular acidification in neutrophils. Cellular immunology. 2009; 259(1):21–6. doi: 10.1016/j.
cellimm.2009.05.008 PMID: 19539899
19. Ichimonji I, Tomura H, Mogi C, Sato K, Aoki H, Hisada T, et al. Extracellular acidification stimulates IL-6
production and Ca(2+) mobilization through proton-sensing OGR1 receptors in human airway smooth
OGR1 Deficiency Is Protective in EAE
PLOSONE | DOI:10.1371/journal.pone.0148439 February 1, 2016 19 / 21
muscle cells. American journal of physiology Lung cellular and molecular physiology. 2010; 299(4):
L567–77. doi: 10.1152/ajplung.00415.2009 PMID: 20656891
20. Figueiredo CA, Drohomyrecky PC, McCarthy SD, Leontyev D, Ma XZ, Branch DR, et al. Optimal atten-
uation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an
intact interleukin-11 receptor. PloS one. 2014; 9(7):e101947. doi: 10.1371/journal.pone.0101947
PMID: 25078447
21. Pino PA, Cardona AE. Isolation of brain and spinal cord mononuclear cells using percoll gradients.
Journal of visualized experiments: JoVE. 2011(48: ).
22. Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, et al. Ovarian cancer G protein-coupled receptor 1,
a newmetastasis suppressor gene in prostate cancer. Journal of the National Cancer Institute. 2007;
99(17):1313–27. PMID: 17728215
23. WuGF, Shindler KS, Allenspach EJ, Stephen TL, Thomas HL, Mikesell RJ, et al. Limited sufficiency of
antigen presentation by dendritic cells in models of central nervous system autoimmunity. Journal of
autoimmunity. 2011; 36(1):56–64. doi: 10.1016/j.jaut.2010.10.006 PMID: 21095100
24. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental aller-
gic encephalomyelitis in Lewis rats after elimination of macrophages. The Journal of experimental med-
icine. 1990; 172(4):1025–33. PMID: 2145387
25. Jiang Z, Jiang JX, Zhang GX. Macrophages: a double-edged sword in experimental autoimmune
encephalomyelitis. Immunology letters. 2014; 160(1):17–22. doi: 10.1016/j.imlet.2014.03.006 PMID:
24698730
26. Rawji KS, Yong VW. The benefits and detriments of macrophages/microglia in models of multiple scle-
rosis. Clinical & developmental immunology. 2013; 2013:948976.
27. Juedes AE, Ruddle NH. Resident and infiltrating central nervous system APCs regulate the emergence
and resolution of experimental autoimmune encephalomyelitis. Journal of immunology. 2001; 166
(8):5168–75.
28. van der Veen RC, Dietlin TA, Dixon Gray J, Gilmore W. Macrophage-derived nitric oxide inhibits the
proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cel-
lular immunology. 2000; 199(1):43–9. PMID: 10675274
29. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, CowdenWB. IFN-gamma is critical to the
control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target
tissue: a possible role for nitric oxide. Journal of immunology. 1999; 163(10):5278–86.
30. Yamazaki T, Akiba H, Koyanagi A, AzumaM, Yagita H, Okumura K. Blockade of B7-H1 on macro-
phages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide produc-
tion. Journal of immunology. 2005; 175(3):1586–92.
31. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, et al. CD11b+Ly-6C(hi) suppressive
monocytes in experimental autoimmune encephalomyelitis. Journal of immunology. 2007; 179
(8):5228–37.
32. Dalton DK, Wittmer S. Nitric-oxide-dependent and independent mechanisms of protection from CNS
inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KOmice. Journal of neu-
roimmunology. 2005; 160(1–2):110–21. PMID: 15710464
33. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, et al. Experimental
autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. Journal of immunology.
1998; 160(6):2940–6.
34. Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. Immunological
reviews. 2014; 262(1):153–66. doi: 10.1111/imr.12218 PMID: 25319333
35. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends in immunology.
2015; 36(3):161–78. doi: 10.1016/j.it.2015.01.003 PMID: 25687683
36. Gold DP, Schroder K, Powell HC, Kelly CJ. Nitric oxide and the immunomodulation of experimental
allergic encephalomyelitis. European journal of immunology. 1997; 27(11):2863–9. PMID: 9394811
37. Prasad R, Giri S, Nath N, Singh I, Singh AK. GSNO attenuates EAE disease by S-nitrosylation-medi-
ated modulation of endothelial-monocyte interactions. Glia. 2007; 55(1):65–77. PMID: 17019693
38. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activa-
tion via reversible disruption of the Jak3/STAT5 signaling pathway. Journal of immunology. 1998; 160
(12):5729–34.
39. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, et al. Myeloid suppressor lines inhibit
T cell responses by an NO-dependent mechanism. Journal of immunology. 2002; 168(2):689–95.
40. Okajima F. Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cellu-
lar signalling. 2013; 25(11):2263–71. doi: 10.1016/j.cellsig.2013.07.022 PMID: 23917207
OGR1 Deficiency Is Protective in EAE
PLOSONE | DOI:10.1371/journal.pone.0148439 February 1, 2016 20 / 21
41. Jianjun Y, Zhang R, Lu G, Shen Y, Peng L, Zhu C, et al. T cell-derived inducible nitric oxide synthase
switches off Th17 cell differentiation. The Journal of experimental medicine. 2013; 210(7):1447–62.
PMID: 23797094
42. NiedbalaW, Alves-Filho JC, Fukada SY, Vieira SM, Mitani A, Sonego F, et al. Regulation of type 17
helper T-cell function by nitric oxide during inflammation. Proceedings of the National Academy of Sci-
ences of the United States of America. 2011; 108(22):9220–5. doi: 10.1073/pnas.1100667108 PMID:
21576463
43. NiedbalaW, Wei XQ, Campbell C, Thomson D, Komai-Koma M, Liew FY. Nitric oxide preferentially
induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via
cGMP. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99
(25):16186–91. PMID: 12451176
44. van der Veen RC, Dietlin TA, Pen L, Gray JD. Nitric oxide inhibits the proliferation of T-helper 1 and 2
lymphocytes without reduction in cytokine secretion. Cellular immunology. 1999; 193(2):194–201.
PMID: 10222062
45. Bogdan C. The multiplex function of nitric oxide in (auto)immunity. The Journal of experimental medi-
cine. 1998; 187(9):1361–5. PMID: 9565628
46. Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J. Nitric oxide accelerates the onset and
increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent
mechanism. Journal of immunology. 1997; 159(10):5132–42.
47. Pahan K, Mondal S. Crosstalk between Nitric Oxide and T helper cells. Journal of clinical & cellular
immunology. 2012; 3(4).
48. MayhanWG. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain
research. 2000; 866(1–2):101–8. PMID: 10825485
49. Boullerne AI, Nedelkoska L, Benjamins JA. Synergism of nitric oxide and iron in killing the transformed
murine oligodendrocyte cell line N20.1. Journal of neurochemistry. 1999; 72(3):1050–60. PMID:
10037476
50. Garthwaite G, Goodwin DA, Batchelor AM, Leeming K, Garthwaite J. Nitric oxide toxicity in CNS white
matter: an in vitro study using rat optic nerve. Neuroscience. 2002; 109(1):145–55. PMID: 11784706
51. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events
induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide
in cortical cell cultures. Proceedings of the National Academy of Sciences of the United States of Amer-
ica. 1995; 92(16):7162–6. PMID: 7638161
52. Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS let-
ters. 2011; 585(23):3715–23. doi: 10.1016/j.febslet.2011.08.004 PMID: 21854776
OGR1 Deficiency Is Protective in EAE
PLOSONE | DOI:10.1371/journal.pone.0148439 February 1, 2016 21 / 21
